A locus control region generates distinct active placental lactogen and inactive growth hormone gene domains in term placenta that are disrupted with obesity
Placenta · 2025
DOI: 10.1016/j.placenta.2025.03.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Placenta, 2025. Verfasst von Yan Jin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pathophysiology, University of Manitoba, Winnipeg, MB, Canada. Hauptthemen laut MEDLINE: Placenta, Placental Lactogen, Locus Control Region, Obesity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Institutes of Health Research.
Abstract (Originalsprache)
INTRODUCTION: Placental villi include an outer syncytiotrophoblast (STB) layer and an inner layer of cytotrophoblasts (CTBs) that fuse to generate the STB layer in pregnancy. While activation of the locus containing the human (h) placental lactogen (hPL) genes (hPL-A/CSH1 and hPL-B/CSH2) begins in the CTBs, their expression in the STB requires epigenetic modifications and interactions between locus control region (LCR) and gene regulatory sequences. No factor that limits or facilitates hPL LCR/gene interactions for locus activation is reported. The paternally-expressed gene 3 (PEG3/PW1) transcription factor was pursued as a candidate. PEG3 is expressed by villous CTBs but not the STB and putative binding sites were identified in hPL-related sequences. METHODS: PEG3 expression was assessed in multiple cell types including in CTB-like JEG-3 cells. PEG3 binding was also assessed in JEG-3 cells and term placenta samples from women with or without maternal obesity, where chromosomal architecture of the hPL gene locus was also examined. RESULTS: In JEG-3 cells, PEG3 was found to bind to hypersensitive site (HS III-V) sequences within the LCR. Knockdown of PEG3 in these cells resulted in increased hPL gene expression. In term placenta, PEG3 binding at placenta-specific HS IV was increased with maternal obesity, where a decrease in hPL RNA levels is seen, while PEG3 binding was reduced in women with obesity who develop insulin-treated gestational diabetes mellitus (O/GDM + Ins), where increased hPL gene expression is observed. Chromatin conformation capture revealed distinct hPL gene domain interactions that are modified with maternal obesity but largely reversed in O/GDM + Ins, correlating with PEG3 binding. DISCUSSION: Decreased PEG3 binding may be required for hPL domain generation and expression during CTB to STB transition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Pathophysiology, University of Manitoba, Winnipeg, MB, Canada.
- Department of Microbiology, University of Manitoba, Winnipeg, MB, Canada.
- Department of Physiology and Pathophysiology, University of Manitoba, Winnipeg, MB, Canada. Electronic address: peter.cattini@umanitoba.ca.
Förderung
- Canadian Institutes of Health Research
Zitieren
APA
Jin, Y., McNicol, I., & Cattini, P. A. (2025). A locus control region generates distinct active placental lactogen and inactive growth hormone gene domains in term placenta that are disrupted with obesity. Placenta. https://doi.org/10.1016/j.placenta.2025.03.012
Vancouver
Jin Y, McNicol I, Cattini PA. A locus control region generates distinct active placental lactogen and inactive growth hormone gene domains in term placenta that are disrupted with obesity. Placenta. 2025. doi:10.1016/j.placenta.2025.03.012
BibTeX
@article{Jin2025,
author = {Jin, Yan and McNicol, Ian and Cattini, Peter A},
title = {A locus control region generates distinct active placental lactogen and inactive growth hormone gene domains in term placenta that are disrupted with obesity},
journal = {Placenta},
year = {2025},
doi = {10.1016/j.placenta.2025.03.012}
}
EUVIMED